Author

Peng-Hui Wang

Institutions: National Yang Ming Chiao Tung University, Taipei Veterans General Hospital

Observed institutions: National Yang Ming Chiao Tung University, Taipei Veterans General Hospital

OpenAlex ID: A5159620267

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial

2026 · Brian M Slomovitz, Jianqing Zhu, et al. · The Lancet

Works count: 1

Citation count:

H-index:

I10-index: